Cargando…
Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?
Lung and colorectal cancers are among the leading causes of death from cancer worldwide. Although topotecan (TPT), a topoisomerase1 inhibitor, is a first- and second-line drug for lung and colon cancers, the development of drug resistance and toxicity still remain as a major obstacle to chemotherape...
Autores principales: | Lozon, Lama, Saleh, Ekram, Menon, Varsha, Ramadan, Wafaa S., Amin, Amr, El-Awady, Raafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479137/ https://www.ncbi.nlm.nih.gov/pubmed/36120345 http://dx.doi.org/10.3389/fphar.2022.938471 |
Ejemplares similares
-
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
por: Madkour, Moustafa M., et al.
Publicado: (2023) -
Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells
por: Al-Hrout, Ala’a, et al.
Publicado: (2018) -
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
por: Alseksek, Rahma K., et al.
Publicado: (2022) -
Safranal Prevents Liver Cancer Through Inhibiting Oxidative Stress and Alleviating Inflammation
por: Abdalla, Youssef, et al.
Publicado: (2022) -
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
por: Ramadan, Wafaa S, et al.
Publicado: (2018)